The non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase GapN is a potential new drug target in Streptococcus pyogenes

The strict human pathogen Streptococcus pyogenes causes infections of varying severity, ranging from self-limiting suppurative infections to life-threatening diseases like necrotizing fasciitis or streptococcal toxic shock syndrome. Here, we show that the non-phosphorylating glyceraldehyde-3-phospha...

Full description

Saved in:
Bibliographic Details
Main Authors: Eisenberg, Philip (Author) , Albert, Leon (Author) , Teuffel, Jonathan (Author) , Zitzow, Eric (Author) , Michaelis, Claudia (Author) , Jarick, Jane (Author) , Sehlke, Clemens (Author) , Große, Lisa (Author) , Bader, Nicole (Author) , Nunes-Alves, Ariane (Author) , Kreikemeyer, Bernd (Author) , Schindelin, Hermann (Author) , Wade, Rebecca C. (Author) , Fiedler, Tomas (Author)
Format: Article (Journal)
Language:English
Published: 15 February 2022
In: Frontiers in microbiology
Year: 2022, Volume: 13, Pages: 1-18
ISSN:1664-302X
Online Access:Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/article/10.3389/fmicb.2022.802427
Get full text
Author Notes:Philip Eisenberg, Leon Albert, Jonathan Teuffel, Eric Zitzow, Claudia Michaelis, Jane Jarick, Clemens Sehlke, Lisa Große, Nicole Bader, Ariane Nunes-Alves, Bernd Kreikemeyer, Hermann Schindelin, Rebecca C. Wade and Tomas Fiedler

MARC

LEADER 00000caa a2200000 c 4500
001 1797607987
003 DE-627
005 20250324090545.0
007 cr uuu---uuuuu
008 220405s2022 xx |||||o 00| ||eng c
024 7 |a 10.3389/fmicb.2022.802427  |2 doi 
035 |a (DE-627)1797607987 
035 |a (DE-599)KXP1797607987 
035 |a (OCoLC)1341458545 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Eisenberg, Philip  |d 1996-  |e VerfasserIn  |0 (DE-588)1254819177  |0 (DE-627)179760922X  |4 aut 
245 1 4 |a The non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase GapN is a potential new drug target in Streptococcus pyogenes  |c Philip Eisenberg, Leon Albert, Jonathan Teuffel, Eric Zitzow, Claudia Michaelis, Jane Jarick, Clemens Sehlke, Lisa Große, Nicole Bader, Ariane Nunes-Alves, Bernd Kreikemeyer, Hermann Schindelin, Rebecca C. Wade and Tomas Fiedler 
264 1 |c 15 February 2022 
300 |a 18 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.04.2022 
520 |a The strict human pathogen Streptococcus pyogenes causes infections of varying severity, ranging from self-limiting suppurative infections to life-threatening diseases like necrotizing fasciitis or streptococcal toxic shock syndrome. Here, we show that the non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase GapN is an essential enzyme for S. pyogenes. GapN converts glyceraldehyde 3-phosphate into 3-phosphoglycerate coupled to the reduction of NADP to NADPH. The knock-down of gapN by antisense peptide nucleic acids (asPNA) significantly reduces viable bacterial counts of S. pyogenes laboratory and macrolide-resistant clinical strains in vitro. As S. pyogenes lacks the oxidative part of the pentose phosphate pathway, GapN appears to be the major NADPH source for the bacterium. Accordingly, other streptococci that carry a complete pentose phosphate pathway are not prone to asPNA-based gapN knock-down. Determination of the crystal structure of the S. pyogenes GapN apo-enzyme revealed an unusual cis-peptide in proximity to the catalytic binding site. Furthermore, using a structural modeling approach, we correctly predicted competitive inhibition of S. pyogenes GapN by erythrose 4-phosphate, indicating that our structural model can be used for in silico screening of specific GapN inhibitors. In conclusion, the data provided here reveal that GapN is a potential target for antimicrobial substances that selectively kill S. pyogenes and other streptococci that lack the oxidative part of the pentose phosphate pathway. 
700 1 |a Albert, Leon  |e VerfasserIn  |4 aut 
700 1 |a Teuffel, Jonathan  |e VerfasserIn  |4 aut 
700 1 |a Zitzow, Eric  |e VerfasserIn  |4 aut 
700 1 |a Michaelis, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Jarick, Jane  |e VerfasserIn  |4 aut 
700 1 |a Sehlke, Clemens  |e VerfasserIn  |4 aut 
700 1 |a Große, Lisa  |e VerfasserIn  |4 aut 
700 1 |a Bader, Nicole  |e VerfasserIn  |4 aut 
700 1 |a Nunes-Alves, Ariane  |e VerfasserIn  |0 (DE-588)1214207375  |0 (DE-627)1725177315  |4 aut 
700 1 |a Kreikemeyer, Bernd  |d 1966-  |e VerfasserIn  |0 (DE-588)114684618  |0 (DE-627)486911276  |0 (DE-576)289805066  |4 aut 
700 1 |8 1\p  |a Schindelin, Hermann  |e VerfasserIn  |0 (DE-588)1275956475  |0 (DE-627)1912212986  |4 aut 
700 1 |a Wade, Rebecca C.  |e VerfasserIn  |0 (DE-588)102801774X  |0 (DE-627)730136000  |0 (DE-576)276591402  |4 aut 
700 1 |a Fiedler, Tomas  |d 1978-  |e VerfasserIn  |0 (DE-588)132483831  |0 (DE-627)522315631  |0 (DE-576)26711415X  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in microbiology  |d Lausanne : Frontiers Media, 2010  |g 13(2022), Artikel-ID 802427, Seite 1-18  |h Online-Ressource  |w (DE-627)642889384  |w (DE-600)2587354-4  |w (DE-576)335527094  |x 1664-302X  |7 nnas  |a The non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase GapN is a potential new drug target in Streptococcus pyogenes 
773 1 8 |g volume:13  |g year:2022  |g elocationid:802427  |g pages:1-18  |g extent:18  |a The non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase GapN is a potential new drug target in Streptococcus pyogenes 
856 4 0 |u https://www.frontiersin.org/article/10.3389/fmicb.2022.802427  |x Verlag  |z lizenzpflichtig  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20250301  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20220405 
993 |a Article 
994 |a 2022 
998 |g 102801774X  |a Wade, Rebecca C.  |m 102801774X:Wade, Rebecca C.  |d 140000  |e 140000PW102801774X  |k 0/140000/  |p 13 
998 |g 1214207375  |a Nunes-Alves, Ariane  |m 1214207375:Nunes-Alves, Ariane  |p 10 
999 |a KXP-PPN1797607987  |e 411207526X 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"18 S."}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"display":"Eisenberg, Philip","family":"Eisenberg","role":"aut","given":"Philip"},{"given":"Leon","role":"aut","family":"Albert","display":"Albert, Leon"},{"family":"Teuffel","role":"aut","given":"Jonathan","display":"Teuffel, Jonathan"},{"given":"Eric","role":"aut","family":"Zitzow","display":"Zitzow, Eric"},{"family":"Michaelis","given":"Claudia","role":"aut","display":"Michaelis, Claudia"},{"given":"Jane","role":"aut","family":"Jarick","display":"Jarick, Jane"},{"family":"Sehlke","given":"Clemens","role":"aut","display":"Sehlke, Clemens"},{"display":"Große, Lisa","given":"Lisa","role":"aut","family":"Große"},{"display":"Bader, Nicole","role":"aut","given":"Nicole","family":"Bader"},{"role":"aut","given":"Ariane","family":"Nunes-Alves","display":"Nunes-Alves, Ariane"},{"family":"Kreikemeyer","given":"Bernd","role":"aut","display":"Kreikemeyer, Bernd"},{"family":"Schindelin","role":"aut","given":"Hermann","display":"Schindelin, Hermann"},{"family":"Wade","given":"Rebecca C.","role":"aut","display":"Wade, Rebecca C."},{"role":"aut","given":"Tomas","family":"Fiedler","display":"Fiedler, Tomas"}],"title":[{"title":"The non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase GapN is a potential new drug target in Streptococcus pyogenes","title_sort":"non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase GapN is a potential new drug target in Streptococcus pyogenes"}],"name":{"displayForm":["Philip Eisenberg, Leon Albert, Jonathan Teuffel, Eric Zitzow, Claudia Michaelis, Jane Jarick, Clemens Sehlke, Lisa Große, Nicole Bader, Ariane Nunes-Alves, Bernd Kreikemeyer, Hermann Schindelin, Rebecca C. Wade and Tomas Fiedler"]},"recId":"1797607987","id":{"eki":["1797607987"],"doi":["10.3389/fmicb.2022.802427"]},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"15 February 2022"}],"note":["Gesehen am 05.04.2022"],"relHost":[{"title":[{"title_sort":"Frontiers in microbiology","title":"Frontiers in microbiology"}],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.2010 -"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 23.12.10"],"part":{"year":"2022","pages":"1-18","volume":"13","text":"13(2022), Artikel-ID 802427, Seite 1-18","extent":"18"},"id":{"issn":["1664-302X"],"zdb":["2587354-4"],"eki":["642889384"]},"origin":[{"publisherPlace":"Lausanne","dateIssuedDisp":"2010-","dateIssuedKey":"2010","publisher":"Frontiers Media"}],"disp":"The non-phosphorylating glyceraldehyde-3-phosphate dehydrogenase GapN is a potential new drug target in Streptococcus pyogenesFrontiers in microbiology","recId":"642889384"}]} 
SRT |a EISENBERGPNONPHOSPHO1520